Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 8, 2008, Pages 1488-1494

  Lu, Ake T ^a   Ogdie, Matthew N ^a   Järvelin, Marjo Ritta ^b   Moilanen, Irma K ^c   Loo, Sandra K ^d   McCracken, James T ^d   McGough, James J ^d   Yang, May H ^d   Peltonen, Leena ^e,f,g   Nelson, Stanley F ^a   Cantor, Rita M ^a,d   Smalley, Susan L ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f UNIVERSITY OF HELSINKI   (Finland)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Association; Attention; Genes; Post traumatic stress disorder

Indexed keywords

CANNABINOID 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABINOID RECEPTOR GENE; CHILD; COMORBIDITY; CONTROLLED STUDY; FAMILY; FEMALE; FINLAND; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NUCLEOTIDE SEQUENCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; COMORBIDITY; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; LOS ANGELES; MALE; MIDDLE AGED; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CANNABINOID; RISK FACTORS; SEX FACTORS; SIBLINGS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 57349125837     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30693     Document Type: Article

References (55)

1. APA. 1994. Diagnostic and statistical manual of mental disorders, 4th edition (DMS-IV). Washington,D.C.: American Psychiatric Association.
2. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG, Rapoport JL, Berg K, Bailey-Wilson JE, Muenke M. 2004. Attention-deficit/ hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75(6):998-1014.
3. Bakker SC, van der Meulen EM, Buitelaar JK, Sandkuijl LA, Pauls DL, Monsuur AJ, van 't Slot R, Minderaa RB, Gunning WB, Pearson PL, et al. 2003. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: Suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72(5):1251-1260.
4. Ballon N, Leroy S, Roy C, Bourdel MC, Charles-Nicolas A, Krebs MO, Poirier MF. 2006. (AAT)n repeat in the cannabinoid receptor gene (CNR1): Association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J 6(2):126-130.
5. Barrero FJ, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J, Garcia Yebenes J. 2005. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 5(2):135-141.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
7. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. 1995. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152(11):1652-1658.
8. Braida D, Limonta V, Malabarba L, Zani A, Sala M. 2007. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404,the anandamide transport inhibitor, in Sprague-Dawley rats. Eur J Pharmacol 555(2-3):156-163.
9. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML. 2001. Prevalence and assessment of attention-deficit/ hyperactivity disorder in primary care settings. Pediatrics 107(3):E43.
10. Castellano C, Rossi-Arnaud C, Cestari V, Costanzi M. 2003. Cannabinoids and memory: Animal studies. Curr Drug Targets CNS Neurol Disord 2(6):389-402.
11. Cuffe SP, Moore CG, McKeown RE. 2005. Prevalence and correlates of ADHD symptoms in the national health interview survey. J Atten Disord 9(2):392-401.
12. Durston S, Mulder M, Casey BJ, Ziermans T, van Engeland H. 2006. Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder. Biol Psychiatry 60(10):1062-1070.
13. Faraone SV, Biederman J. 2005. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord 9(2):384-391.
14. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
15. Fyer AJ, Mannuzza S, Chapman TF, Martin LY, Klein DF. 1995. Specificity in familial aggregation of phobic disorders. Arch Gen Psychiatry 52(7):564-573.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. 2002. The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229.
17. Gadzicki D, Muller-Vahl KR, Heller D, Ossege S, Nothen MM, Hebebrand J, Stuhrmann M. 2004. Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am J Med Genet Part B 127B(1):97-103.
18. Hariri AR, Drabant EM, Weinberger DR. 2006. Imaging genetics: Perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 59(10):888-897.
19. Hebebrand J, Dempfle A, Saar K, Thiele H, Herpertz-Dahlmann B, Linder M, Kiefl H, Remschmidt H, Hemminger U, Warnke A, et al. 2006. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 11(2):196-205.
20. Heller D, Schneider U, Seifert J, Cimander KF, Stuhrmann M. 2001. The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users. Addict Biol 6(2):183-187.
21. Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J. 2006. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet Part B 141B(5):499-503.
22. Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, Rhee SH, Smolen A, Krauter K, Hewitt JK, et al. 2006. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet Part B 141(8):895-901.
23. Horvath S, Xu X, Laird NM. 2001. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9(4):301-306.
24. Hudziak JJ, Derks EM, Althoff RR, Rettew DC, Boomsma DI. 2005. The genetic and environmental contributions to attention deficit hyperactivity disorder as measured by the Conners' Rating Scales-Revised. Am J Psychiatry 162(9):1614-1620.
25. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411(6837):599-603.
26. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980-988.
27. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, et al. 2005. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol Psychiatry 57(11):1442-1451.
28. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. 2006. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716-723.
29. Kim SJ, Badner J, Cheon KA, Kim BN, Yoo HJ, Kim SJ, Cook E Jr, Leventhal BL, Kim YS. 2005. Family-based association study of the serotonin transporter gene polymorphisms in Korean ADHD trios. Am J Med Genet Part B 139B(1):14-18.
30. King JA, Barkley RA, Barrett S. 1998. Attention-deficit hyperactivity disorder and the stress response. Biol Psychiatry 44(1):72-74.
31. Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF. 2004. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: Confirmation of association of ADHD with DRD4 and D RD5. Mol Psychiatry 9(7):711-717.
32. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19 (Suppl 1):S36-S42.
33. Lange C, Laird NM. 2002a. On a general class of conditional tests for family-based association studies in genetics: The asymptotic distribution, the conditional power, and optimality considerations. Genet Epidemiol 23(2):165-180.
34. Lange C, Laird NM. 2002b. Power calculations for a general class of family-based association tests: Dichotomous traits. Am J Hum Genet 71(3):575-584.
35. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. 1982. Best estimate of lifetime psychiatric diagnosis: A methodological study. Arch Gen Psychiatry 39(8):879-883.
36. Lunetta KL, Faraone SV, Biederman J, Laird NM. 2000. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet 66(2):605-614.
37. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. 2002. Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis. Psychiatr Genet 12(4):207-215.
38. Martinez-Gras I, Hoenicka J, Ponce G, Rodriguez-Jimenez R, Jimenez-Arriero MA, Perez-Hernandez E, Ampuero I, Ramos-Atance JA, Palomo T, Rubio G. 2006. (AAT)n repeat in the cannabinoid receptor gene, CNV R1: Association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci 256(7):437-441.
39. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S. 2005. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: Findings from multiplex families. Am J Psychiatry 162(9):1621-1627.
40. Nigg JT, Casey BJ. 2005. An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol 17(3):785-806.
41. Ogdie MN, Fisher SE, Yang M, Ishii J, Francks C, Loo SK, Cantor RM, McCracken JT, McGough JJ, Smalley SL, et al. 2004. Attention deficit hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 75(4):661-668.
42. Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA, Martin L, Durkin K, Blair C, Royal J, et al. 2006. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 63(7):795-807.
43. Ponce G, Hoenicka J, Rubio G, Ampuero I, Jimenez-Arriero MA, Rodriguez-Jimenez R, Palomo T, Ramos JA. 2003. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol Psychiatry 8(5):466-467.
44. Pressman LJ, Loo SK, Carpenter EM, Asarnow JR, Lynn D, McCracken JT, McGough JJ, Lubke GH, Yang MH, Smalley SL. 2006. Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD. J Am Acad Child Adolesc Psychiatry 45(3):346-354.
45. Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A. 2007. CB(1)-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem 101(2):389-396.
46. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, Kocher K, Miller K, Guschwan S, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29(2):223-228.
47. Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B. 2005. Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 28(3):207-219.
48. Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR. 2002. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65(3):221-224.
49. Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM. 2004. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and binging/purging subtypes. Am J Med Genet Part B 125B(1):126-130.
50. Smalley SL, McGough JJ, Del'Homme M, New Delman J, Gordon E, Kim T, Liu A, McCracken JT. 2000. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39(9):1135-1143.
51. Smalley SL, McGough JJ, Moilanen IK, Loo SK, Taanila A, Ebeling H, Hurtig T, Humphrey LA, McCracken JT, Varilo T, et al. 2007. Prevalence and psychiatric Comorbidity of attention deficit hyperactivity disorder in an adolescent Finnish population. J Am Acad Child Adolesc Psychiatry 46(12):1575-1583.
52. Tsai SJ, Wang YC, Hong CJ. 2000. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet 10(3):149-151.
53. Tsai SJ, Wang YC, Hong CJ. 2001. Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders. Am J Med Genet 105(3):219-221.
54. Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S. 2002. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 7(5):515-518.
55. Urry HL, van Reekum CM, Johnstone T, Kalin NH, Thurow ME, Schaefer HS, Jackson CA, Frye CJ, Greischar LL, Alexander AL, et al. 2006. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J Neurosci 26(16):4415-4425.